You are viewing: US Pulse Oximeter Market analysis
Part of: Pulse Oximeter Market (Global)

The US Pulse Oximeter Market was valued at $1523.1 Million in 2025 and projected to reach to $2783.8 Million by 2030, representing a compound annual growth rate of 9.0%. The US pulse oximeter market is positioned for sustained expansion through 2030, driven by rising incidence of chronic respiratory and cardiovascular conditions, aging demographics, and increased healthcare spending.

US Pulse Oximeter Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Pulse Oximeter Market Trends and Insights

  • This 9.0% compound annual growth rate reflects strong demand driven by increasing prevalence of respiratory and cardiovascular diseases across the US population.
  • The US market benefits from advanced healthcare infrastructure, high adoption of remote patient monitoring technologies, and significant investment in home healthcare solutions. In the US, the pulse oximeter market is being propelled by aging demographics and rising awareness of preventive healthcare.
  • The US healthcare system's shift toward value-based care and home-based monitoring has accelerated pulse oximeter adoption among both clinical and consumer segments.
  • By 2030, the US market is expected to capture substantial growth as telemedicine integration and wearable pulse oximetry devices gain traction throughout the country. The US pulse oximeter landscape is characterized by continuous innovation and competitive intensity.
  • Market players in the US are focusing on developing non-invasive, portable, and connected devices to meet evolving clinical and consumer needs.
  • The US regulatory environment, supported by FDA approvals and reimbursement policies, continues to facilitate market expansion through 2030..

Key Market Statistics

  • CAGR (2025-2030) 9.0% CAGR
  • Market Size, 2025 ~USD 1523.1 Million
  • Forecast, 2030 ~USD 2783.8 Million
  • Country US

US Pulse Oximeter Market Overview

Market Valuation Growth :

The US pulse oximeter market is valued at $1,523.1 million in 2025 and is projected to reach $2,783.8 million by 2030, representing an 82.8% increase over the five-year forecast period.

Strong CAGR Performance :

The US market is growing at a 9.0% CAGR, outpacing the global average of 8.7%, indicating accelerating demand and market maturation within the United States healthcare sector.

Disease Prevalence Drivers :

Increasing prevalence of respiratory and cardiovascular diseases across the US population is fueling demand for pulse oximeters, with chronic conditions affecting millions of Americans requiring continuous monitoring.

Advanced Healthcare Infrastructure :

The US benefits from sophisticated healthcare infrastructure and high adoption rates of remote patient monitoring technologies, enabling widespread integration of pulse oximeters in clinical and home settings.

US Pulse Oximeter Market Dynamics

  • The shift toward remote patient monitoring and home healthcare solutions is accelerating adoption across both hospital and consumer segments.
  • Technological advancements in wearable pulse oximetry and integration with digital health platforms are creating new growth opportunities.
  • Additionally, heightened awareness of respiratory health post-pandemic and reimbursement support from major US healthcare payers are expected to sustain market momentum.
  • The competitive landscape will likely intensify as established medical device manufacturers and emerging digital health companies vie for market share in this high-growth segment..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US pulse oximeter market will grow from $1,523.1M (2025) to $2,783.8M (2030) at a 9.0% CAGR, outpacing global growth.
    • US demand is driven by aging demographics, rising chronic disease prevalence, and accelerating adoption of remote patient monitoring in the US healthcare system.
    • The US market is increasingly dominated by wearable and connected pulse oximetry devices integrated with telemedicine platforms across the US.
    • FDA approvals and favorable reimbursement policies in the US continue to support market expansion and innovation through 2030.

    Pulse Oximeter Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONNECTED PULSE OXIMETERS (Technology)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.7% from 2025 to 2030
    Largest Segment ADULTS (Age Group)
    Market Size Base Year (Billions) ~USD 3.92 (2025)
    Revenue Forecast (Billions) ~USD 5.95 (2030)
    Segments Covered Product, Type, Technology, Age Group, End User

    US Pulse Oximeter Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product

    • Equipment
    • Sensors

    By Type

    • Bedside/Tabletop Pulse Oximeters
    • Disposable Sensors
    • Fingertip Pulse Oximeters
    • Handheld Pulse Oximeters
    • Infants
    • Neonatal
    • Otc Home Use
    • Portable Pulse Oximeters
    • Prescription Home Use
    • Reusable Sensors
    • Wearable Pulse Oximeters

    By Technology

    • Connected Pulse Oximeters
    • Conventional Pulse Oximeters

    By Age Group

    • Adult
    • Adults
    • Pediatric

    By End User

    • Ambulatory Care Centers
    • Ambulatory Care Settings
    • Home Care Settings
    • Hospitals
    • Other End User
    • Other End Users
    • Primary Centers
    • Urgent Care Centers

    US: PULSE OXIMETER MARKET, BY END USER, 2023–2032

    Segment2023202420252029203020312032CAGR (%)
    AMBULATORY CARE CENTERS119.7126136.3184.9199.1214.3230.87.8
    HOME CARE SETTINGS339.3360.7394.4557.9606.8660718.38.9
    HOSPITALS665.8710.4779.81122.31225.11337.51454.39.3
    OTHER END USERS72.27784.5121.4132.5144.7158.19.4
    PRIMARY CENTERS40.442.245.359.663.76872.77
    URGENT CARE CENTERS71.375.782.7116.6126.7137.7149.78.8
    TOTAL1308.813921523.12162.82353.92562.12783.89

    Target Audience

    • Medical Device Manufacturers : US-based and international pulse oximeter manufacturers need detailed market data to optimize product development, identify growth segments, and establish competitive pricing strategies within the American healthcare market.
    • Healthcare Providers & Hospitals : US hospitals, clinics, and healthcare systems require market intelligence to make informed procurement decisions, evaluate supplier options, and plan capital investments in patient monitoring technologies.
    • Investment & Private Equity Firms : Investors evaluating opportunities in US healthcare technology need comprehensive market analysis to assess portfolio companies, identify acquisition targets, and determine valuation multiples in the pulse oximetry sector.
    • Digital Health & Remote Monitoring Companies : US-based telehealth and remote patient monitoring platforms need market data to integrate pulse oximetry solutions, understand adoption rates, and quantify addressable market opportunities in home healthcare.
    • Healthcare Consultants & Analysts : Management consultants, market researchers, and healthcare analysts require US-specific pulse oximeter market data to support client advisory work, competitive benchmarking, and strategic planning initiatives.

    Key Companies in the US Pulse Oximeter Market

    CompanyHQOwnershipStrongest segments
    MEDTRONICIrelandPublic CompanyEquipment (Bedside and multiparameter-integrated),Sensors (Reusable and disposable),Portable – Handheld,
    MASIMOUnited StatesPrivate CompanyEquipment – Bedside Monitors,Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Consumer,
    NIHON KOHDEN CORPORATIONJapanPublic CompanyEquipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld, wearable-capable, transport),Equipment – Fingertip/consumer-style oximeters,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyEquipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld and wearable clinical devices),Equipment – Fingertip/consumer-oriented devices,
    ICU MEDICAL, INC.United StatesPublic CompanyEquipment – Bedside Pulse Oximeters and Multi-parameter Monitors,Sensors – Reusable and Disposable Oximetry Sensors,Portable – Handheld and Clinical Wearable Oximeters,
    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.ChinaPublic CompanyEquipment – Bedside / Multiparameter Monitors,Equipment – Portable Handheld,Wearable Pulse Oximeters,
    GE HEALTHCAREUnited StatesPublic CompanyEquipment – Bedside and multi-parameter monitors with integrated SpO2,Sensors and disposables,Portable – Handheld and transport oximeters,
    CONTEC MEDICAL SYSTEMS CO., LTD.ChinaPublic CompanyPortable – Fingertip,Portable – Handheld,Portable – Wearable,
    DRäGERWERK AG & CO. KGAAGermanyPublic CompanyEquipment – Bedside Monitors (Conventional & Connected),Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Basic Portable,
    OSI SYSTEMS, INC.United StatesPublic CompanyEquipment – Bedside Monitors,Equipment – Portable (Handheld/Wearable),Sensors and Disposables,
    A&D COMPANY, LIMITEDJapanPublic CompanyEquipment – Portable Handheld,Equipment – Portable Wearable,Equipment – Portable Fingertip,

    MEDTRONIC

    Medtronic is a publicly traded medical device company founded in 1949 and headquartered in Ireland, employing approximately 95,000 people globally.

    MASIMO

    Masimo is a private medical technology company established in 1989 in the United States with 2,200 employees specializing in patient monitoring solutions.

    NIHON KOHDEN CORPORATION

    Nihon Kohden Corporation is a Japanese public company founded in 1951 that employs 6,116 people and operates in the medical device sector.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a large multinational public company founded in 1891 in the Netherlands with 63,670 employees operating across healthcare and technology sectors.

    ICU MEDICAL, INC.

    ICU Medical, Inc. is a publicly traded medical device company founded in 1984 in the United States with 13,000 employees.

    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

    Lepu Medical Technology is a publicly traded Chinese medical device company founded in 1999 in Beijing with 8,689 employees.

    GE HEALTHCARE

    GE Healthcare is a publicly traded healthcare technology company founded in 2022 in the United States with 54,000 employees.

    CONTEC MEDICAL SYSTEMS CO., LTD.

    Contec Medical Systems is a publicly traded Chinese medical device company founded in 1996 with 1,712 employees.

    DRäGERWERK AG & CO. KGAA

    Drägerwerk AG & Co. KGaA is a publicly traded German medical and safety technology company founded in 1889 with 16,033 employees.

    OSI SYSTEMS, INC.

    OSI Systems, Inc. is a publicly traded technology company founded in 1987 in the United States with 7,337 employees.

    A&D COMPANY, LIMITED

    A&D Company, Limited is a large publicly traded Japanese company founded in 1920 with 64,394 employees operating in measurement and medical device sectors.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise US market valuation data ($1,523.1M in 2025) and verified growth projections through 2030, enabling accurate financial forecasting and investment decision-making specific to the American market.
    • Competitive Positioning Intelligence : Understand the US competitive landscape, market dynamics, and regional demand drivers to identify opportunities for market entry, expansion, or product differentiation within the high-growth American healthcare sector.
    • Strategic Business Planning : Leverage detailed US market insights to develop targeted go-to-market strategies, pricing models, and distribution channels optimized for American healthcare providers, hospitals, and consumer segments.
    • Investment & Risk Assessment : Evaluate the US pulse oximeter market's 9% CAGR performance against global benchmarks to assess investment viability, market saturation levels, and long-term revenue potential in the American healthcare ecosystem.
    • Regulatory & Reimbursement Clarity : Gain insights into US-specific regulatory requirements, reimbursement policies, and healthcare infrastructure factors that directly impact market adoption, pricing strategies, and profitability for pulse oximeter manufacturers.

    Frequently asked questions

    What is the current size of the US pulse oximeter market in 2025?

    The US pulse oximeter market is valued at $1,523.1 million in 2025, representing significant demand across clinical and consumer segments in the US.

    What is the projected size of the US pulse oximeter market by 2030?

    The US pulse oximeter market is forecast to reach $2,783.8 million by 2030, reflecting an 82.8% increase from 2025 levels.

    What is the CAGR for the US pulse oximeter market?

    The US pulse oximeter market is expected to grow at a 9.0% compound annual growth rate from 2025 to 2030.

    What factors are driving growth in the US pulse oximeter market?

    Key drivers in the US include aging demographics, rising prevalence of respiratory and cardiovascular diseases, adoption of remote patient monitoring, and integration with telemedicine platforms.

    How does the US pulse oximeter market compare to global trends?

    The US pulse oximeter market is growing at 9.0% CAGR, which exceeds the global CAGR of 8.7%, indicating stronger demand and market maturity in the US.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    This research study used widespread secondary sources; directories, databases such as Dun & Bradstreet, Bloomberg BusinessWeek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pulse oximeters market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply & demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.

    A breakdown of the primary respondents is provided below:

    Pulse Oximeter Market

    Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pulse oximeter market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was made for the major players (who contribute at least 60-70% of the market share at the global level). Also, the global pulse oximeter market was split into various segments and sub-segments based on:

    • List of major players operating in the pulse oximeter devices  market at the regional and/or country level
    • Product mapping of various pulse oximeter device manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from the pulse oximeter segment (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2024
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global pulse oximeter market 
    Pulse Oximeter Market

    Data Triangulation

    After arriving at the market size, the total pulse oximeters market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

    Market Definition

    A pulse oximeter is a non-invasive medical device used to measure the blood's oxygen saturation level (SpO2) and pulse rate. It typically works by emitting light through a body part—usually a fingertip or earlobe—and detecting the amount of oxygenated and deoxygenated hemoglobin based on light absorption.

    Stakeholders

    • Medical device manufacturers
    • Regulatory authorities (e.g., the US FDA and the EMA, among others)
    • Hospitals & clinics
    • Physicians & anesthesiologists
    • Home healthcare providers
    • Distributors & suppliers
    • Research institutes & labs
    • Health insurance companies
    • Government health departments
    • Patients & end-users
    • Medical research institutes
    • Business research & consulting service providers

    Report Objectives

    • To define, describe, segment, and forecast the pulse oximeters market by product, type, age group, technology, end user, and region.
    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pulse oximeter market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the pulse oximeters market in five regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the pulse oximeters market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the pulse oximeters market
    • To benchmark players within the pulse oximeters market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Pulse Oximeter Market Report

    Full forecast, segment splits, and company analysis for all Pulse Oximeter Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status